Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 132, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2020.110833
Keywords
Chronic kidney disease; Shenkang injection; Traditional Chinese medicine; Renal fibrosis
Funding
- National Natural Science Foundation of China [81373943, 81573583]
- Zunyi City Science and Technology Plan of China [ZunshiKeheHZ (2019)20]
Ask authors/readers for more resources
Chronic kidney disease (CKD) is one of the most common conditions which significantly increases the risk for serious health outcomes. Epidemiological investigations have shown that CKD has become a serious global health problem. At present, there are no treatments for CKD, thus the need for an effective and safe treatment for this condition. Shenkang Injection (SKI), which is an herbal medication in Chinese Medicine, has been used in the management and treatment of CKD and has achieved favorable therapeutic effects. The purpose of this paper is to review the clinical efficacy, mechanism of action, and safety profile of SKI when used in CKD, and to provide comprehensive potential evidence for its clinical application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available